Launching the second EASL-Lancet Commission on liver health in Europe: prevention, case-finding and early diagnosis to reduce liver-related mortality
Triggered by the rising burden of liver disease, the Lancet and the European Association for the Study of the Liver (EASL) jointly arranged a Commission to explore the landscape of liver health…
Policy Webinar: Steatotic Liver Disease (SLD) – The missing piece in the NCD puzzle
The European Association for the Study of the Liver (EASL), as part of the Healthy Livers, Healthy Lives Coalition held a policy webinar on 31 January 2024. Moderated by Nicola Bedlington and…
DECISION: Revolutionising liver disease treatment for improved patient outcomes
The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent…
The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer
Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona…
Tribute to Sir Roy Calne (1930-2024)
It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed…
Public Health Community United Against Alcohol-Related Harm in the SANT Report on Non-Communicable Diseases
Press Release Brussels, 12 December 2023 As the European Parliament prepares for the vote on the Subcommittee on Health (SANT)’s Non-Communicable Diseases (NCDs) report, leading health organisations across the EU are actively…
